Press Releases May 5, 2026 09:51 AM

Sprott Inc. Declares First Quarter 2026 Dividend

Sprott Inc. announces first quarter 2026 dividend declaration of $0.40 per common share.

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
SII

Sprott Inc., a global asset manager specializing in precious metals and critical materials investments, declared a first quarter 2026 dividend of US$0.40 per common share payable on June 3, 2026. The dividend will be paid in Canadian or U.S. dollars depending on the shareholder's residency and intermediary participation. The dividend is designated as an eligible dividend for Canadian tax purposes.

Sprott Inc. Declares First Quarter 2026 Dividend
SII
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Sprott declared a first quarter 2026 dividend of US$0.40 per common share payable June 3, 2026.
  • Dividend payments will vary in currency (USD or CAD) based on shareholder residency and intermediary.
  • Sprott focuses on precious metals and critical materials investments with listings on NYSE and TSX under SII.

TORONTO, May 05, 2026 (GLOBE NEWSWIRE) -- Sprott Inc. (“Sprott” or the “Company”) (NYSE/TSX: SII) announced today that its Board of Directors has declared a first quarter 2026 dividend of US$0.40 per common share, payable on June 3, 2026 to shareholders of record at the close of business on May 19, 2026.

Registered shareholders who are residents of Canada as reflected in the Company’s shareholders register, as well as beneficial holders (i.e., shareholders who hold their common shares through a broker or other intermediary) whose intermediary is a participant in CDS Clearing and Depositary Services Inc. or its nominee, CDS & Co. (“CDS”), will receive their dividend in Canadian dollars, calculated based on the spot price exchange rate on June 3, 2026. Registered shareholders resident outside of Canada as reflected in Sprott’s shareholders register, including the United States, as well as beneficial holders whose intermediary is a participant in The Depository Trust Company or its nominee, Cede & Co., will receive their dividend in U.S. dollars. However, beneficial holders whose intermediary is a participant in CDS, may elect to change the currency of their dividend payments to U.S. dollars and can contact their broker for more details. Registered shareholders, other than CDS, who are residents of Canada and wish to receive their dividend in U.S. dollars should make arrangements to deposit their common shares with CDS, and make a currency election, prior to May 19, 2026.

The dividend is designated as an eligible dividend for Canadian income tax purposes.

About Sprott

Sprott is a global asset manager focused on precious metals and critical materials investments. We are specialists. We believe our in-depth knowledge, experience and relationships separate us from the generalists. Our investment strategies include Exchange Listed Products, Managed Equities and Private Strategies. Sprott has offices in Toronto, New York, Connecticut and California and the Company’s common shares are listed on the New York Stock Exchange and the Toronto Stock Exchange under the symbol (SII). For more information, please visit www.sprott.com.

Investor contact information:

Glen Williams
Senior Managing Partner
Investor and Institutional Client Relations
(416) 943-4394
gwilliams@sprott.com 


Risks

  • Dividend amount and payment are subject to board discretion and future business performance.
  • Currency fluctuations could impact the effective dividend value for shareholders paid in Canadian dollars.
  • Market volatility in precious metals and critical materials sectors could influence Sprott's financial results and dividend sustainability.

More from Press Releases

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress Jun 14, 2026 Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 Jun 14, 2026 Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026 Jun 14, 2026 Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control Jun 14, 2026 Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026